Chemodynamic
therapy (CDT), as a powerful tumor therapeutic approach
with low side effects and selective therapeutic efficiency, has gained
much attention. However, the low intracellular content of H2O2 and the cellular bottleneck of low intracellular oxidative
reaction rates at tumor sites have limited the antitumor efficacy
of CDT. Herein, a series of sulfur-deficient engineered biodegradable
cobalt sulfide quantum dots (CoS
x
QDs)
were constructed for improved synergistic photothermal- and hyperthermal-enhanced
CDT of tumors through regulating the photothermal conversion efficiency
(PCE) and Fenton-like activity. Through defect engineering, we modulated
the PCE and promoted the Fenton catalytic capability of CoS
x
QDs. With increasing defect sites, the Fenton-like
activity improved to generate more toxic •OH, while
the photothermal effect declined slightly. In light of above unique
superiorities, the best synergistic effects of CoS
x
QDs were obtained through comparing their PCE and catalytic
activity by regulating the sulfur defect fraction degree in these
QDs during the synthetic process. In addition, the ultrasmall size
and biodegradation endowed QDs with the ability to be rapidly decomposed
to ions that were easily excreted after therapy, thus reducing biogenic
accumulation in the body with lowered systemic side effects. The in
vitro/vivo results demonstrated that the photothermal- and hyperthermal-enhanced
chemodynamic effect of CoS
x
QDs can enable
remarkable anticancer properties with favorable biocompatibility.
In this study, the defect-driven mechanism for the photothermal-enhanced
Fenton-like reaction provides a flexible strategy to deal with different
treatment environments, holding great promise in developing a multifunctional
platform for cancer treatment in the future.
Photodynamic therapy (PDT) has provided a promising approach for treatment of solid tumors, while the therapeutic efficacy is often limited due to hypoxic tumor microenvironment, resulting in tumor metastasis. We...
Infrared neural stimulation with the assistance of photothermal transducers holds great promise as a mini-invasive neural modulation modality. Optical nanoparticles with the absorption in the near-infrared (NIR) window have emerged as excellent photothermal transducers due to their good biocompatibility, surface modifiability, and tunable optical absorption. However, poor activation efficiency and limited stimulation depth are main predicaments encountered in the neural stimulation mediated by these nanoparticles. In this study, we prepared a targeted polydopamine (PDA)-coated gold (Au) nanoparticles with specific binding to thermo-sensitive ion channel as nanotransducers for second near-infrared (NIR-II) photo-stimulation of neurons in rats. The targeted Au nanoparticles were constructed via conjugation of anti-TRPV1 antibody with PEGylated PDA-coated Au nanoparticles and thus exhibited potent photothermal performance property in the second NIR (NIR-II) window and converted NIR-II light to heat to rapidly activate Ca2+ influx of neurons in vitro. Furthermore, wireless photothermal stimulation of neurons in living rat successfully evoke excitation in neurons in the targeted brain region as deep as 5 mm beneath cortex. This study thus demonstrates a remote-controlled strategy for neuromodulation using photothermal nanotransducers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.